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Abstract 11 
Purpose: This study had two objectives: 1) to examine whether the validity of the 12 
supramaximal verification test for maximal oxygen uptake (?̇?O2max) differs in children 13 
and adolescents when stratified for sex, body mass and cardiorespiratory fitness (CRF); 14 
and 2) to assess sensitivity and specificity of primary and secondary objective criteria 15 
from the incremental test to verify ?̇?O2max. Methods: 128 children and adolescents (76 16 
males, 52 females; 9.3-17.4 y) performed a ramp-incremental test to exhaustion on a cycle 17 
ergometer followed by a supramaximal test to verify ?̇?O2max. Results: Supramaximal tests 18 
verified ?̇?O2max in 88% of participants. Group incremental test peak ?̇?O2 was greater than 19 
the supramaximal test (2.27 ± 0.65 L·min-1 and 2.17 ± 0.63 L·min-1; P<0.001), although 20 
were correlated (r =0.94; P<0.001). No differences were found in ?̇?O2 plateau attainment 21 
or supramaximal test verification between sexes, body mass or CRF statuses (all P>0.18). 22 
Supramaximal test time to exhaustion predicted supramaximal test ?̇?O2max verification 23 
(P=0.040). Primary and secondary objective criteria had insufficient sensitivity (7.1-24 
24.1%) and specificity (50-100%) to verify ?̇?O2max. Conclusion: The utility of 25 
supramaximal testing to verify ?̇?O2max is not affected by sex, body mass or CRF status. 26 
Supramaximal testing should replace secondary objective criteria to verify ?̇?O2max.  27 
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Introduction 44 
Maximal oxygen uptake (?̇?O2max), typically expressed in relation to a measure of body 45 
size, is the “gold-standard” measure of cardiorespiratory fitness (CRF) (10). A valid 46 
measurement of ?̇?O2max is important in children and adolescents as a high CRF in youth 47 
is associated with a lower risk of cardiovascular disease in youth (24), a reduced risk of 48 
myocardial infarction (17) and all-cause mortality (18) in adult life. Traditionally, the 49 
presence of a plateau of ?̇?O2 at, or close to exhaustion, during incremental exercise has 50 
been used as the primary criterion for attainment of ?̇?O2max (36). However, as only 51 
between 10-50% of children display a plateau across different testing protocols (5, 29, 52 
30, 32), with  the reasons behind this still being unclear, the term ?̇?O2peak is routinely used 53 
to denote the highest ?̇?O2 recorded without a plateau (1). Secondary objective criteria 54 
(e.g. respiratory exchange ratio (RER) and maximal heart rate (HRmax) thresholds) (3, 33) 55 
are therefore often used to verify that the ?̇?O2peak attained was a “true” ?̇?O2max for children 56 
and adolescents but significantly underestimate ?̇?O2max (5). While, the validity of 57 
secondary objective criteria has recently been challenged (5, 26), their use is still 58 
commonplace in contemporary pediatric research (e.g. 15, 28).  59 
To overcome the validity issues with the primary and secondary criteria, the 1990s saw 60 
the emergence of a supramaximal test to verify that the ?̇?O2peak that had been achieved in 61 
the incremental test is a “true” ?̇?O2max. This requires participants to exercise at a power 62 
output greater than the maximal power output achieved during the incremental test (3, 33) 63 
and is a variation of the original protocol proposed by Taylor et al. (36). However, the 64 
supramaximal verification tests were initially conducted on separate days (3, 33), which 65 
may not be feasible, due to logistical requirements of supplementary laboratory visits. 66 
Recently, it has been shown that children can successfully perform the supramaximal 67 
verification test on the same day as the incremental test, following a short rest of 10-15 68 
min following the incremental test (5, 7, 31), and is now the recommended protocol for 69 
?̇?O2max determination (6, 27). 70 
While the supramaximal verification test is an elegant solution to determine ?̇?O2max in 71 
children and adolescents, not all participants have their ?̇?O2max confirmed in the 72 
supramaximal test. Between 8-26% of participants have been reported as not having 73 
?̇?O2max verified (5, 31), but a recent paper reported a non-verification rate of 100% of 74 
children (7). Previous studies have suggested that non-verification may be related to 75 
factors such as sex, body mass, CRF and/or maturity status (4, 7, 9) but the current 76 
pediatric literature is based on small sample sizes (n = 9-40) (3, 5, 31, 33), which limits 77 
examination of these variables on ?̇?O2max verification. Consequently, male and female 78 
data have been combined for analysis (5), despite known sex-differences in ?̇?O2max and 79 
body composition (2, 3). Recently it has been shown that adults with low CRF were less 80 
likely to have their ?̇?O2max confirmed in the supramaximal test than those with a higher 81 
CRF status (4), but this has not been investigated in children and adolescents. Few studies 82 
(4, 31) have compared individual ?̇?O2peak values from the incremental test to the 83 
supramaximal test, instead comparing the group means (3, 33) which may be misleading 84 
as ?̇?O2max testing is conducted on an individual basis. The effect of body mass status on 85 
the verification of ?̇?O2max using supramaximal exercise has only been studied by 86 
Bhammar et al. (7) who found both obese (n = 9) and non-obese (n = 9) children to have 87 
a significantly greater ?̇?O2peak in the supramaximal test. Brown et al. (9) have also 88 
suggested that maturity status may influence plateau attainment during an incremental 89 
test, with 23.8% of men achieving a plateau compared with 12.5% of boys, but this has 90 
not been investigated in the context of the supramaximal verification test. Finally, the 91 
effect of the time to exhaustion (TTE) in the supramaximal test on the utility of the 92 
supramaximal verification test is worthy of consideration. TTE in studies where between 93 
74-92% of children had ?̇?O2max verified is reported to be between 60 to 90 s in duration 94 
(5, 31). However, Bhammar et al. (7) reported that no children had their ?̇?O2max verified 95 
by the supramaximal verification test and reported a TTE in excess of 125 s. Conversely, 96 
a short TTE (e.g. of less than 60 s) could indicate that fatigue is reached before attainment 97 
of ?̇?O2max, possibly due to insufficient effort or because the intensity was too high for the 98 
?̇?O2 kinetic response to attain ?̇?O2max (16). 99 
The purpose of the current study was to extend previous work in this area (5) and further 100 
examine the validity of testing procedures to determine ?̇?O2max in a large sample of 101 
healthy children and adolescents. Specifically, our aims were to: 1) examine whether the 102 
validity of the supramaximal verification test differs in children and adolescents when 103 
stratified for sex, body mass and CRF status; and 2) assess the sensitivity and specificity 104 
of primary (i.e. plateau) and secondary (i.e. RER and HR thresholds) objective criteria to 105 
verify the ?̇?O2peak attained in the incremental test as ?̇?O2max when compared to a 106 
supramaximal confirmed ?̇?O2max measurement. 107 
Methods 108 
Participants: 109 
Existing data from our laboratory were pooled and retrospectively analysed to produce a 110 
sample of 128 healthy children and adolescents. Only data from 13 participants that form 111 
the final sample have previously been published elsewhere to examine the validity of the 112 
supramaximal test (5). All data were collected as part of studies which originally were 113 
granted ethics approval by institutional and NHS ethics committees (where relevant). 114 
Inclusion criteria for this study were: 1) 8-<18 years old and; 2) ?̇?O2max assessed using a 115 
combined incremental and supramaximal test protocol, conducted on the same day; 3) 116 
ostensibly healthy participants and; 4) cycling modality. All children and their parent(s) 117 
or guardian(s) gave informed assent and consent, respectively, to participate in the 118 
original studies. 119 
Anthropometry: 120 
Body mass (Seca 877, Seca Ltd, Birmingham, UK) was measured to the nearest 0.1 kg 121 
and stature (Harpenden, Holtain Ltd, Crymych, UK) was measured to the nearest 0.01 m. 122 
Body mass index (BMI) was calculated, and age-appropriate criteria were used to classify 123 
participants into non-overweight and overweight/obese categories (12). Maturity 124 
(somatic) offset from the age of peak height velocity (APHV) was calculated through the 125 
equations by Moore et al. (21), which have been validated in two external samples where 126 
90% of predictions are within ± 1 year. Pre-peak height velocity (PHV) children were 127 
defined as >-1 year from PHV, circa-PHV children were -1 to 1 year from PHV and post-128 
PHV children were >1 year from PHV. 129 
Incremental and supramaximal test protocols: 130 
A combined incremental-ramp and supramaximal test to exhaustion was used to 131 
determine ?̇?O2max (5). Participants were instructed to cycle on an electronically braked 132 
ergometer (Lode Excalibur, Groningen, The Netherlands) at a constant self-selected 133 
cadence between 70 and 90 revolutions per minute throughout the tests. Participants 134 
cycled for ~ 3 min (range 1 to 3 min) at 20 watts (W) to warm up before immediately 135 
commencing the incremental-ramp protocol where the power output increased by 10-30 136 
W.min-1, depending on the participants’ age and body size, to attempt to elicit exhaustion 137 
between 8 and 12 min. Exhaustion was defined as a decrease in cadence below 60 138 
revolutions per minute for 5 consecutive seconds, despite strong verbal encouragement. 139 
This was followed by 3 min 30 s (range 0 to 10 min) cool down cycling at 20 W. A rest 140 
period of ~ 25 min (range = 5 to 84 min) followed before the commencement of the 141 
supramaximal test, which began with a warm up of 3 min at 20 W. The resistance was 142 
then increased in a “step” transition to either ~105% (n = 117) or ~110% (n = 11) of the 143 
peak power achieved in the incremental test and participants were required to cycle to 144 
exhaustion. Following the test, the participant completed a cool down cycling at 20 W. 145 
The measurement of ?̇?O2peak from the ramp-incremental test to exhaustion has a 146 
coefficient of variation of 4.1% (37).  147 
Gas collection and analysis: 148 
Pulmonary gas exchange and heart rate (HR) were measured using online systems (Cortex 149 
Metalyzer III B, Leipzig, Germany: n =106; EX671; Morgan Medical, Kent, UK, 150 
combined with mass spectrometry and a turbine flow meter VMM-401; Interdace 151 
Associates, Laguna Niguel, California, USA: n =13; and Medgraphics Cardiorespiratory 152 
Diagnostics, Express Series, Gloucester, UK: n =9). All systems were appropriately 153 
calibrated for gas and volume before each test as per manufacturers’ recommendations. 154 
?̇?O2max was accepted as the highest 10-15 second average of ?̇?O2 recorded in either the 155 
incremental or supramaximal tests (5). To control for body-size, both the ratio standard 156 
and allometric (via log-linear regression, (38)) models were used to scale ?̇?O2max for body 157 
mass. Although allometric procedures are superior for scaling ?̇?O2 (39), normative data 158 
are unavailable to classify the children and adolescents into CRF groups. Therefore, the 159 
ratio standard method to scale for body mass was used to group participants into CRF 160 
statuses of low, average and high CRF based on age and sex related normative values (8). 161 
Low CRF was defined as > 1 standard deviation (SD) below the age and sex specific 162 
mean normative value, average CRF was defined as falling within 1 SD either side of the 163 
age and sex specific mean normative value, and high CRF was defined as > 1 SD above 164 
the age and sex specific mean normative value.  165 
Criteria and ?̇?O2 profile classification during incremental exercise: 166 
The methods proposed by Day et al. (13) were used to define a plateau and classify the  167 
?̇?O2 responses during incremental exercise into a linear, acceleration or deceleration 168 
profile using GraphPad Prism (GraphPad Software Inc., San Diego, California, USA). A 169 
linear regression of the ?̇?O2-intensity relationship was plotted over the ‘linear’ portion of 170 
the ?̇?O2 profile, where the data points from the first 2 minutes and the last 3 minutes of 171 
exercise were excluded. The linear function was then extrapolated and compared to the 172 
residuals to analyse the ?̇?O2 profile at exhaustion for an accelerated, decelerated (i.e. 173 
plateau) or linear response. An accelerated profile required the positive residual to be 174 
≥5% of the peak power projected ?̇?O2 whereas a decelerated profile required the negative 175 
residual to be ≥5% of the projected ?̇?O2. A linear response was classified by residuals 176 
that were <5% of the peak power projected ?̇?O2, either side of the extrapolated line. 177 
The secondary objective criteria to verify ?̇?O2max were selected from the pediatric 178 
literature (1, 3, 5, 7, 14) and included: RER ≥ 1, RER ≥ 1.1, HRmax > 85% of the age-179 
predicted maximum (calculated using 220 minus age), HRmax > 95% age-predicted 180 
maximum and HRmax > 195 beats
.min-1. HR data are not available for 18 participants, and 181 
therefore were excluded from the HR criteria analyses. 182 
Criteria for verification of ?̇?O2max using the supramaximal test: 183 
As used by Barker et al. (5), ?̇?O2max was considered verified by the supramaximal test if 184 
the ?̇?O2 increased by <5% compared to the ?̇?O2peak attained in the incremental test to 185 
account for the typical within-participant error of measurement for ?̇?O2max (25, 37). 186 
Statistical analyses: 187 
Data were analysed using IBM SPSS (v24, Armonk, NY, USA) and presented as mean ± 188 
standard deviation (SD), unless otherwise stated. Statistical significance was accepted at 189 
an alpha of 0.05 and data were checked for normality using the Shapiro-Wilk test. Data 190 
were log transformed when the normality assumption was violated. Independent t-tests 191 
were conducted to examine mean differences in participant characteristics between sex 192 
and between body mass statuses within each sex. Chi-squared analyses were performed 193 
to test for significant differences in the percentages of males compared to females, 194 
overweight compared to non-overweight, and different CRF status’ that achieved a 195 
plateau during the incremental test and had their ?̇?O2max verified with the supramaximal 196 
test. Paired t-tests and effect sizes (ES) using Cohen’s d thresholds (< 0.2 trivial, 0.2 = 197 
small. 0.5 = medium, 0.8 = large) (11) were used to compare the ?̇?O2peak values from the 198 
incremental and supramaximal tests for the whole sample, and when stratified for sex, 199 
body mass and CRF status. The relationship between the ?̇?O2peak recorded in the 200 
incremental and supramaximal tests was assessed using Pearson’s product moment 201 
correlation coefficients. Bland-Altman (20) analyses were used to show the absolute 202 
(L·min-1) and relative (%) level of agreement in the ?̇?O2max recorded via the incremental 203 
and supramaximal tests with 95% limits of agreement (95% LoA) for the whole group 204 
combined, and based on sex, body mass and CRF status. Checks for proportional bias 205 
were undertaken using Pearson’s correlation and satisfied for all Bland-Altman plots.   206 
Separate logistic regression analyses were run to identify 1) significant predictors of 207 
plateau attainment in the incremental test and; 2) verification of ?̇?O2max through the use 208 
of the supramaximal test. The variables tested in both models were age (years), sex, body 209 
mass status (overweight/obese or non-overweight), APHV (pre-, circa-, post-PHV), 210 
?̇?O2max expressed using the ratio standard and allometric methods, CRF status (low, 211 
average or high) and incremental test TTE (s). The supramaximal test TTE (s), 212 
supramaximal test intensity (% of peak power attained in the incremental test) and rest 213 
period between the incremental and supramaximal test (s) were also included for 214 
predicting ?̇?O2max verification using the supramaximal test. Variables were entered using 215 
the backward stepwise (likelihood ratio) method. 216 
Primary and secondary objective criteria from the incremental test were assessed for their 217 
sensitivity (ability to correctly identify attainment of “true” ?̇?O2max) and specificity 218 
(ability to correctly identify non-attainment of “true” ?̇?O2max) to verify ?̇?O2peak in the 219 
incremental test as ?̇?O2max when compared to the supramaximal test verification method. 220 
Each of the criteria was also assessed for their positive and negative predictive value i.e. 221 
the likelihood that a positive or negative result from the criteria for attainment of “true” 222 
?̇?O2max in the incremental test is the correct result. The equations below (19) were used 223 
to calculate sensitivity, specificity and the positive and negative predictive value for each 224 
criteria. The ability of each criterion to confirm ?̇?O2max was assessed, allowing for 5% 225 
error at an individual level and compared to whether the supramaximal test was able to 226 
verify ?̇?O2max. Receiver operator characteristic (ROC) curves (1-specificity vs sensitivity) 227 
were also used to calculate the area under the curve (AUC). 228 
Sensitivity = True positives / (True positives + False negatives) 229 
Specificity = True negatives / (True negatives + False positives) 230 
Positive predictive value = True positives / (True positives + False positives) 231 
Negative predictive value = True negatives / (True negatives + False negatives) 232 
Results 233 
Table 1 presents the participants’ characteristics and physiological responses to the 234 
incremental and supramaximal tests by sex and body mass status. The males had a greater 235 
ramp test TTE (P<0.001), ramp and supramaximal test absolute ?̇?O2peak (both P<0.001), 236 
supramaximal test RERpeak (P=0.010), ratio standard ?̇?O2max (P<0.001) and 237 
allometrically scaled ?̇?O2max (P<0.001) than the females. By contrast, the females had 238 
higher BMI (P=0.032), APHV (P=0.022) and ramp test RERpeak (P<0.001) than the 239 
males. Overweight males had a higher age (P=0.018), stature (P=0.025), body mass 240 
(P<0.001), BMI (P<0.001), APHV (P=0.012), ramp test absolute ?̇?O2peak (P=0.007), 241 
supramaximal test TTE (P=0.003) and supramaximal test absolute ?̇?O2peak (P=0.001), 242 
and lower ratio standard ?̇?O2max (P=0.002) compared with non-overweight males. 243 
Furthermore, overweight females had greater body mass (P=0.004) and BMI (P<0.001) 244 
and lower ratio standard ?̇?O2max (P<0.001) and lower allometrically scaled ?̇?O2max 245 
(P=0.004) than non-overweight females. The mean ratio standard ?̇?O2max was greater in 246 
the non-overweight children and adolescents compared with the overweight children and 247 
adolescents (46 ± 10 mL·kg-1·min-1 vs. 36 ± 8 mL·kg-1·min-1; P<0.001). 248 
*** Insert Table 1 *** 249 
Incremental and supramaximal responses: whole group 250 
Analysis of individual participant ?̇?O2-intensity profiles revealed 27% (n= 35) of 251 
participants demonstrated a ?̇?O2 plateau during the incremental test, 14% (n=18) had an 252 
accelerated ?̇?O2 profile and 59% (n=75) had a linear ?̇?O2 profile. When comparing the 253 
?̇?O2peak values obtained from the incremental and supramaximal test on an individual 254 
basis, 88% (n=112) of children and adolescents had their ?̇?O2peak in the incremental test 255 
verified as their “true” ?̇?O2max. For the remaining 12% who did not have ?̇?O2max verified, 256 
the ?̇?O2peak recorded was between 6 and 23% greater than that recorded in the incremental 257 
test. 258 
For the entire sample, the ?̇?O2peak recorded in the incremental test (2.27 ± 0.65 L·min-1) 259 
was higher than the supramaximal test (2.17 ± 0.63 L·min-1; P<0.001; ES = 0.15), and 260 
the two were correlated (r=0.94; P<0.001). 261 
Figure 1 shows the absolute (1A) and relative (1D) differences in the incremental and 262 
supramaximal test ?̇?O2peak for the whole group combined. Mean absolute and relative bias 263 
was -0.10 L·min-1 and -4.6% with LoA as -0.52 to 0.32 L·min-1 and -22 to 13%, 264 
respectively. 265 
*** Insert Figure 1 *** 266 
Incremental and supramaximal responses: influence of sex 267 
There were no differences in the proportion of plateau observations during the 268 
incremental test between males and females (29%; n = 22 vs. 25%; n = 13; P=0.62). 269 
Similarly, no differences were found in the proportion of supramaximal tests that verified 270 
?̇?O2max between males and females (89%; n = 68 vs. 85%; n = 44; P=0.41). 271 
The mean absolute ?̇?O2peak of the males recorded in the incremental test (2.48 ± 0.73 272 
L·min-1) was greater than the supramaximal test (2.36 ± 0.72 L·min-1; P<0.001; ES = 273 
0.17). Likewise, the mean absolute ?̇?O2peak recorded for the females in the incremental 274 
test was higher than in the supramaximal test (1.96 ± 0.31 L·min-1 and 1.89 ± 0.34 L·min-275 
1, respectively; P=0.007; ES = 0.22). Incremental and supramaximal test ?̇?O2peak values 276 
were correlated (males r=0.95 and females r=0.85; both P<0.001). 277 
Figure 1 depicts the Bland-Altman plots for absolute (1B and 1C) and percentage (1E and 278 
1F) difference in ?̇?O2peak recorded between the incremental and supramaximal tests for 279 
each sex. Mean absolute and relative bias for the males was -0.12 L·min-1 and -5.4% with 280 
LoA as -0.58 to 0.33 L·min-1 and -23 to 13%, respectively. The absolute and relative 281 
mean bias for the females was -0.06 L·min-1 and -3.5% with LoA as -0.41 to 0.29 L·min-282 
1 and -21 to 14%, respectively. 283 
Incremental and supramaximal responses: influence of body mass status 284 
No difference was found between the proportion of ?̇?O2 plateau observations between 285 
the non-overweight and overweight children and adolescents (26%; n = 28 vs. 37%; n = 286 
7; P=0.31). Furthermore, no difference was found between the proportion of non-287 
overweight compared with overweight children and adolescents who had their ?̇?O2max 288 
verified in the supramaximal test (89%; n = 97 vs. 79%; n = 15; P=0.22). 289 
The mean absolute ?̇?O2peak for non-overweight children and adolescents was greater in 290 
the incremental test compared with the supramaximal test (2.27 ± 0.63 L·min-1 vs. 2.13 ± 291 
0.54 L·min-1; P<0.001; ES = 0.24). In contrast, the mean absolute ?̇?O2peak was not 292 
different for the overweight children and adolescents between the incremental and 293 
supramaximal tests (2.57 ± 0.79 L·min-1 vs. 2.54 ± 0.81 L·min-1; P=0.65; ES = 0.04). The 294 
?̇?O2peak recorded in the incremental and supramaximal tests were correlated for each 295 
group (non-overweight children and adolescents r=0.94, overweight children and 296 
adolescents r=0.95; both P<0.001). 297 
Figure 2 displays the absolute (2A & 2B) and percentage (2C & 2D) differences in the 298 
?̇?O2peak from the incremental and supramaximal tests for non-overweight and overweight 299 
children and adolescents. The absolute and relative mean bias for non-overweight 300 
children and adolescents was -0.11 L·min-1 and -5.2%, and LoA were -0.51 to 0.29 L·min-301 
1 and -22 to 12%, respectively. Mean absolute and relative bias for overweight children 302 
and adolescents was -0.03 L·min-1 and -1.5% with LoA as -0.54 to 0.49 L·min-1 and -21 303 
to 18%, respectively. 304 
*** Insert Figure 2 *** 305 
Incremental and supramaximal responses: influence of CRF status 306 
A ?̇?O2 plateau was demonstrated by 27% (n = 12) of the low CRF group in the 307 
incremental test compared with 28% (n = 17) of the average CRF group and 26% (n = 6) 308 
of the high CRF group (all P>0.84). Similarly, there were no differences between CRF 309 
statuses for supramaximal test verification which occurred for 87% (n = 39) of the low 310 
CRF group, 85% (n = 51) of the average CRF group and 96% (n = 22) of the high CRF 311 
group (all P>0.18). 312 
Mean absolute ?̇?O2peak was higher in the incremental compared with the supramaximal 313 
test for the low (2.08 ± 0.62 L·min-1 vs. 2.02 ± 0.64 L·min-1; P=0.007; ES = 0.10), average 314 
(2.38 ± 0.55 L·min-1 vs. 2.26 ± 0.50 L·min-1; P=0.001; ES = 0.23) and high (2.33 ± 0.87 315 
L·min-1 vs. 2.21 ± 0.86 L·min-1; P=0.003; ES = 0.14) CRF groups, respectively. The mean 316 
absolute ?̇?O2peak from incremental and supramaximal testing were correlated for the low 317 
(r=0.97), average (r=0.88) and high (r=0.98) CRF groups (P<0.001 for all). 318 
Figure 3 displays the absolute (3A, 3B & 3C) and relative (3D, 3E & 3F) differences in 319 
?̇?O2peak from the incremental and supramaximal tests for low (3A & 3D), average (3B & 320 
3E) and high (3C & 3F) CRF groups. The absolute and relative mean bias for the low 321 
CRF group was -0.06 L·min-1 and -3.3% with LoA as -0.37 to 0.25 L·min-1 and -18 and 322 
12%. Average CRF absolute and relative mean bias was -0.12 L·min-1 and -5.1%, and 323 
LoA were -0.62 to 0.38 L·min-1 and -25 to 14%. For the high CRF group, the absolute 324 
and relative mean bias was -0.12 L·min-1 and -6.0% with LoA as -0.49 to 0.24 L·min-1 325 
and -23 to 11%. 326 
*** Insert Figure 3 *** 327 
Predicting plateau attainment in the incremental test: 328 
Of the variables entered into the model, no variables were predictors for attaining a ?̇?O2 329 
plateau in the incremental test (P>0.30 for all). 330 
Predicting verification of ?̇?O2max in the supramaximal test: 331 
TTE on the supramaximal test was the only predictor of whether the supramaximal test 332 
can verify the ?̇?O2peak attained in the incremental test as ?̇?O2max (P=0.040; odds ratio = 333 
0.978; 95% confidence limits = 0.958-0.999). A longer supramaximal test TTE decreased 334 
the likelihood that ?̇?O2peak would be verified as ?̇?O2max (β=-0.022; standard error = 0.011). 335 
The regression equation below predicts supramaximal test verification. 336 
Supramaximal test verification (Y) = 4.212 + (Supramaximal Test TTE [s] * -0.022) 337 
Sensitivity and specificity of primary and secondary objective criteria: 338 
Table 2 displays the sensitivity and specificity analysis on the primary and secondary 339 
objective criteria compared with the supramaximal test, as well as the positive and 340 
negative predictive values. All criteria had low sensitivity (7.1-24.1%) but the majority 341 
had high specificity (78.6-100%), apart from the plateau attainment (50%). Both primary 342 
and secondary criteria had high positive predictive values (77.1-100%). By contrast, 343 
negative predictive values were low for all criteria (8.6-14.7%) excluding the HRmax > 344 
195 beats.min-1 (92.9%). The AUC were low, ranging from 0.527 to 0.629. 345 
*** Insert Table 2 *** 346 
Discussion 347 
The main findings of the study were: 1) 88% of children and adolescents had their 348 
absolute ?̇?O2max verified in the supramaximal test which had a tendency to result in a ~ 349 
5% decrease in absolute ?̇?O2peak in most, but not all of the sample; 2) the utility of the 350 
supramaximal test to verify ?̇?O2maxwas similar when stratified for sex, body mass or CRF 351 
status; 3) TTE on the supramaximal test was the only significant predictor of ?̇?O2peak 352 
being verified as ?̇?O2max in the supramaximal test whereas there were no significant 353 
predictors of plateau attainment in the ramp test and; 4) primary (plateau) and secondary 354 
(HR and RER thresholds) objective criteria from the incremental test have insufficient 355 
sensitivity and specificity to validate attainment of ?̇?O2max in children. 356 
The majority of our participants had their ?̇?O2max verified in the supramaximal test (88%), 357 
which is line with most (5, 31) but not all (7) of the literature. For example, recent findings 358 
(7) showed that none of the obese and non-obese children had their ?̇?O2max verified in the 359 
supramaximal test. This difference in findings may be due to methodological differences 360 
(e.g. their use of Douglas bags), or the smaller sample size (7). Alternatively, it could be 361 
because the participants in Bhammar et al.’s study (7) had a supramaximal TTE of greater 362 
than two minutes, which is uncommon in both the adult and pediatric literature (4, 5, 31) 363 
and not in line with our findings (whole group = 98 ± 23 s, with 11 participants >120 s). 364 
In the current study, supramaximal test TTE was a significant negative predictor for the 365 
supramaximal test confirming attainment of ?̇?O2max which could explain the lack of 366 
verification of ?̇?O2max observed in Bhammar et al.’s (7) study. The longer TTE may 367 
reflect that the incremental test was sub-optimal and terminated early before ?̇?O2max was 368 
attained. However, it should be noted that although statistically significant, the finding 369 
that the supramaximal test TTE was a significant predictor of ?̇?O2max verification is 370 
unlikely to be meaningful due to significance level in the logistic regression being 371 
P=0.040 and CLs confidence limits = 0.958-0.999. Furthermore, we were not able to 372 
identify a cut-off threshold for supramaximal test non-verification based on TTE. 373 
Mean ?̇?O2peak for the whole group was significantly lower in the supramaximal test, 374 
although the effect size was trivial, contradicting the pediatric literature (5, 7), but 375 
supporting a recent study in adults (4). A previous paper by Barker et al. (5) showed a 376 
similar but non-significant (P=0.09) ~ 4% decrease in ?̇?O2peak in the supramaximal test 377 
compared with the incremental test in a small sample of 13 children. Robben et al. (31) 378 
reported a smaller negative mean bias of -0.02 L·min-1 in a sample of 27 healthy children 379 
whereas Bhammar et al. (7), found a positive mean bias of 0.12 L·min-1 for the 380 
supramaximal test in a small sample of 9 obese and 9 non-obese children.  The reason for 381 
finding a significant difference between the ?̇?O2peak in the incremental and supramaximal 382 
test, which is not in line with the literature, could be due to our much larger sample size 383 
providing greater statistical power to detect smaller differences between the ?̇?O2peak 384 
recorded in each test. Bland Altman analysis revealed more variation in differences 385 
between the incremental and supramaximal tests through wider limits of agreement than 386 
previous studies; -0.52 to 0.32 L·min-1 for the whole sample compared with -0.09 to 0.33 387 
L·min-1 (7) and -0.15 to 0.10 L·min-1 (31), respectively. Therefore, when examining the 388 
effectiveness of the supramaximal test it is important to include individual participant 389 
analysis to prevent misinterpretation due to responses being concealed when analysed on 390 
a group mean level. 391 
Both males and females had significantly lower mean absolute ?̇?O2peak values obtained in 392 
the supramaximal test than the incremental test, opposing the findings of Robben et al. 393 
(31) who found no significant difference between tests for either sex.  This could be 394 
because of their much lower sample size, providing lower statistical power to detect small 395 
differences. However, although the differences were significant, effect sizes showed this 396 
difference was trivial for the males and small for the females. Our results also show a 397 
significantly lower mean absolute ?̇?O2peak recorded in the supramaximal test compared 398 
with the incremental test for the non-overweight children and adolescents (5.2%) with a 399 
small effect size for this difference but not for the overweight children and adolescents (-400 
1.5%) who had a trivial effect size. This contradicts the results of Bhammar et al.’s (7) 401 
study who reported ?̇?O2peak was significantly greater in the verification test in both obese 402 
and non-obese children. In addition, this is the first study to assess the effect of CRF status 403 
on the ?̇?O2 response between the incremental and supramaximal test in a pediatric 404 
population. We found that there was a significant decrease in ?̇?O2peak in the supramaximal 405 
test than the incremental test for all CRF statuses, although effect sizes showed the 406 
difference to be trivial for low and high CRF and small for average CRF. The magnitude 407 
of the decrease within the groups was consistent with when we separated the group by 408 
sex or body mass status. Astorino and DeRevere (4) demonstrated in adults that CRF may 409 
be related to the ability of the supramaximal test to verify “true” ?̇?O2max with less fit 410 
individuals more likely to increase their ?̇?O2 in the supramaximal test than average or 411 
high fit individuals (4 low fit participants vs. 1 moderate/high fit participant respectively). 412 
In contrast, we found no significant differences between the different levels of CRF 413 
statuses on the percentage of children and adolescents who had their ?̇?O2max verified 414 
through the supramaximal test. Astorino and DeRevere’s (4) finding in adults may result 415 
from early termination of the initial ramp test in the low fit participants as they had a 416 
significantly lower TTE on the incremental test compared with moderate and high fit 417 
participants (9.1 ± 1.2 min vs. 10.4 ± 1.0 min and 10.8 ± 1.1 min, respectively). This 418 
might be due to lack of motivation from the low-fit participants, possibly due to their 419 
unfamiliarity with the demands of maximal intensity exercise (27). Despite these 420 
differences, the original findings in the current study indicate that the validity of the 421 
supramaximal test to verify ?̇?O2max does not appear to be influenced by sex, body mass 422 
or CRF status in children and adolescents. 423 
It has been noted that the manipulation of recovery period and its effect on ?̇?O2max 424 
verification using the supramaximal test is an under researched area (35), and to our 425 
knowledge this is the first study to examine this concept in a pediatric group. Whilst it 426 
was not a systematically manipulated outcome, the rest period between the incremental 427 
and supramaximal test was not a significant predictor of ?̇?O2max verification in the 428 
supramaximal test suggesting there is no effect of the duration of recovery on the 429 
measurement of ?̇?O2max in a healthy pediatric population. 430 
The low plateau attainment in the incremental test in this study (27%) is consistent with 431 
the pediatric literature (5, 33) and was consistently found between sex, body mass and 432 
CRF statuses, highlighting the need for the supramaximal verification test as the 433 
alternative method to identify ?̇?O2max in children and adolescents. Similarly, Wood et al. 434 
(40) found overweight adults were no less likely to show a plateau than non-overweight 435 
adults. However, early treadmill work by Myers et al. (23) led to the suggestion that the 436 
occurrence of a ?̇?O2 plateau might be a random occurrence because, although all 437 
participants demonstrated a plateau in the initial incremental test, three of these did not 438 
plateau in the subsequent incremental test. The more recent findings provide some 439 
evidence to refute the suggestion by Myers et al. (23) since if it were a random occurrence, 440 
studies would be reporting different attainment levels of a plateau with some reporting 441 
lower plateau attainment and others reporting much higher plateau attainment. Our 442 
investigation into potential predictors of plateau attainment during the incremental test 443 
(e.g. age, sex, CRF status) did not find any significant predictors. Thus, we are unable to 444 
offer further explanation as to why plateau attainment is low in children and adolescent 445 
during the incremental test. Previous research has suggested that maturation may 446 
influence attainment of a ?̇?O2 plateau because almost double the number of adult males 447 
(23.8%) achieved a plateau compared with the boys at Tanner stages 1 or 2 (12.5%) (9), 448 
but we did not find maturity (somatic) status to be a significant predictor for attaining a 449 
plateau, nor for supramaximal test verification. However, this could be due to differences 450 
in sample size as Brown et al. (9) only studied 16 young boys, protocol differences since 451 
the study was conducted on a treadmill rather than a cycle ergometer or due to Brown et 452 
al. having a wider range of maturation statuses (comparing children Tanner stages 1-2 to 453 
adults Tanner stage 5) than the present study. 454 
Murias et al. (22) recently stated that the supramaximal test should not be used as the gold 455 
standard in ?̇?O2max measurement based on their analysis of adult males where no 456 
significant differences were found between ?̇?O2peak observed in the incremental and 457 
supramaximal tests. Instead, the authors advocate the use of secondary criteria from the 458 
initial incremental test. However, in agreement with Bhammar et al. (7), our results do 459 
not show any of the primary or secondary objective criteria to have a sufficient level of 460 
both sensitivity and specificity to support their use to verify attainment of ?̇?O2max in the 461 
incremental test in children and adolescents. Based on the use of a plateau criterion alone 462 
in the incremental test, only 27% of the population would have been deemed to have 463 
attained ?̇?O2max, but after the use of the supramaximal test, this increased to 88% 464 
regardless of sex, body mass and CRF status. Therefore, it is apparent that attainment of 465 
a ?̇?O2max plateau in the incremental test is not an essential feature for ?̇?O2max to be 466 
identified in children and adolescents. Additionally, the low AUCs from the ROC 467 
analyses for the primary and secondary criteria based on the incremental test (all <0.629), 468 
further demonstrates their poor ability to accurately validate ?̇?O2max attainment, which 469 
does not support the recent recommendation by Murias et al.’s (22). Furthermore, 470 
although ?̇?O2max is typically attained in the incremental test (88% in our sample) in 471 
children and adolescents, the attainment of “true” ?̇?O2max is not certain until the 472 
supramaximal test has been performed because secondary objective criteria significantly 473 
underestimate ?̇?O2max (5, 26). It is therefore essential that the supramaximal test is 474 
performed to ensure a valid measurement of ?̇?O2max, because even though the secondary 475 
objective criteria are often used in combination (15, 25), combining multiple poor 476 
methods does not make a good method to verify ?̇?O2max. This may be especially important 477 
in clinical groups or unfit populations due to their inexperience with performing maximal 478 
intensity exercise (27) and less experienced research teams may have lower validation 479 
rates with the supramaximal test. Consequently, our data support previous proposals for 480 
pediatric and adults groups (5, 27) that the use of primary and secondary objective criteria 481 
from the incremental test should be discontinued in favour of the use of the supramaximal 482 
test (5) when determining ?̇?O2max. 483 
The major strength of this study is that, for the first time, the sample has been stratified 484 
based on sex, body mass and CRF statuses, made possible by our large sample size of 485 
128 ostensibly healthy children and adolescents. Within the large sample, there was a 486 
broad range of CRF statuses (22.6-72.1 mL·kg-1·min-1) and maturation status’. However, 487 
although the overall sample size was large, it was lacking participants who were classed 488 
as overweight, especially for the girls – likely due to a self-selection bias for involvement 489 
in exercise studies. A further limitation of this study is that CRF status was determined 490 
using the ratio standard scaling for body mass, which may have resulted in 491 
misclassification for some participants. However, we are not aware of normative CRF 492 
data to classify CRF status using allometric scaling for body mass. Emerging data show 493 
that the supramaximal test is equally useful in clinical groups (34) and the variables 494 
investigated in this paper should be assessed in clinical and adult populations in case they 495 
are significant predictors of a ?̇?O2 plateau or supramaximal test verification. Additionally, 496 
the literature needs to address the issue of the remaining 12% of children who did not 497 
have their ?̇?O2max verified in the supramaximal test, whether that is by investigating the 498 
utility of conducting a secondary supramaximal test on the same day or on a separate day, 499 
or whether a supplementary incremental and supramaximal test is required. 500 
In conclusion, although only 27% had a plateau after the incremental test, the 501 
supramaximal test verified ?̇?O2max in 88% of children and adolescents and was equally 502 
robust when participants were stratified for sex, body mass, maturation and CRF status. 503 
TTE on the supramaximal test was the only significant predictor of ?̇?O2max being verified 504 
in the supramaximal test, with a longer TTE suggesting the initial incremental test was 505 
prematurely terminated (either by the experimenter or participant). The secondary 506 
objective criteria commonly used in the literature failed to have adequate levels of both 507 
sensitivity and specificity and their use in research should be discontinued. Results of this 508 
study support the use of the supramaximal test to verify ?̇?O2max in a pediatric population. 509 
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Table 1 – Participant characteristics and physiological responses to the incremental and supramaximal tests 610 
 Males Females 
Overall  
(n =76) 
Non-overweight 
(n =65) 
Overweight  
(n =11) 
Overall 
(n =52) 
Non-overweight 
(n=44) 
Overweight  
(n =8) 
Age (y) 13.3 ± 1.9 b 13.1 ± 1.9 b** 14.6 ± 1.1 b 13.9 ± 1.6 b 14.0 ± 1.6 b 13.7 ± 1.5 b 
Stature (m) 1.61 ± 0.15 b 1.60 ± 0.16 b** 1.71 ± 0.08 b 1.60 ± 0.10 b 1.61 ± 0.09 b 1.60 ± 0.12 b 
Body mass (kg) 52.9 ± 16.7 b 48.7 ± 13.4 b** 78.0 ± 11.3 b 54.2 ± 10.3 b 52.2 ± 8.0 b*** 65.5 ± 14.6 b 
BMI (kg·m-2) 19.8 ± 3.6 b* 18.7 ± 2.1 ** 26.7 ± 3.0 20.9 ± 2.8 b 20.1 ± 1.9 b*** 25.4 ± 3.1 b 
APHV (y) 0.9 ± 1.7* 0.8 ± 1.7** 2.0 ± 1.0 1.8 ± 1.4 1.8 ± 1.4 1.6 ± 1.5 
CRF status  
(% low, average, high) 
29, 45, 26 22, 48, 31 73, 27, 0 44, 50, 6 39, 55, 7 75, 25, 0 
Ratio standard ?̇?O2max 
(mL·kg-1·min-1) 
49 ± 10 b* 50 ± 10 ** 40 ± 7 38 ± 7 b 38 ± 6 b*** 31 ± 5 b 
Allometrically scaled 
?̇?O2max (mL·kg-0.66·min-1) 
187 ± 33 b* 189 ± 34 181 ± 31 147 ± 23 b 
150 ± 22 
 b*** 
128 ± 17 b 
Peak ramp ?̇?O2 (L·min-1) 2.48 ± 0.73 b* 2.39 ± 0.70 b** 3.03 ± 0.68 b 1.96 ± 0.31 b 1.96 ± 0.30 1.94 ± 0.40 
 27 
Peak supramaximal ?̇?O2 
(L·min-1)  
2.36 ± 0.72 b* 2.24 ± 0.66 b** 3.04 ± 0.70 b 1.89 ± 0.34 b 1.90 ± 0.35 b 1.86 ± 0.31 b 
Peak ramp HR 
(beats.min-1) 
193 ± 10a 194 ± 10a 191 ± 10a 194 ± 7a 195 ± 7a 192 ± 6 
Peak supramaximal HR 
(beats.min-1) 
187 ± 11a 186 ± 11a 188 ± 9a 190 ± 8a 191 ± 8a 186 ± 7 
Peak ramp RER 1.19 ± 0.10 * 1.19 ± 0.10 b 1.19 ± 0.08 b 1.26 ± 0.09 1.27 ± 0.09 1.24 ± 0.10 
Peak supramaximal RER 1.18 ± 0.12 * 1.18 ± 0.12 1.21 ± 0.11 1.24 ± 0.14 1.25 ± 0.14 b 1.19 ± 0.13 b 
Ramp TTE (s) 568 ± 126 b* 570 ± 125 557 ± 139 483 ± 110 b 489 ± 113 b 452 ± 96 b 
Supramaximal TTE (s) 98 ± 25 b 94 ± 21 b** 119 ± 35 b 99 ± 20 b 100 ± 19 91 ± 23 
Data presented as mean ± standard deviation (SD). BMI = body mass index. APHV = age from peak height velocity. CRF = 611 
cardiorespiratory fitness. HR = heart rate. RER = respiratory exchange ratio. TTE = time to exhaustion. a = denotes incomplete data. b = 612 
denotes data log transformed for t-test analysis. * = significant difference of males compared with females. ** = significant difference of 613 
non-overweight males compared with overweight males. *** = significant difference of non-overweight females compared with 614 
overweight females.615 
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Table 2 – Sensitivity and specificity analysis of primary and secondary objective 616 
criteria to verify ?̇?O2max 617 
 Plateau 
achieved in 
incremental 
test? 
RER>1.0 RER>1.1 HRmax> 85% 
age 
predicted 
maximum 
HRmax> 
195 
beats.min-1 
HRmax> 
95% age 
predicted 
maximum 
Sensitivity (%) 24.1 7.1 17.9 10.4 14.6 15.6 
Specificity (%) 50.0 100.0 87.5 78.6 92.9 100.0 
PPV (%) 77.1 100.0 90.9 76.9 93.3 100.0 
NPV (%) 8.6 13.3 13.2 11.3 92.9 14.7 
AUC 0.629 0.536 0.527 0.555 0.537 0.578 
PPV = positive predictive value, NPV = negative predictive value, AUC = area under 618 
receiver operator characteristic curve. 619 
 620 
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